| 1 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
|
| 2 |
Southeast Asia Infectious Disease Clinical Research Network. Causes and outcomes of sepsis in southeast Asia: a multinational multicentre cross-sectional study[J]. Lancet Glob Health, 2017, 5 (2): e157-e167.
|
| 3 |
Gupta N, Richter R, Robert S, et al. Viral sepsis in children[J]. Front Pediatr, 2018 (6): 252.
|
| 4 |
Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses[J]. Lancet, 2020, 395 (10235): 1517-1520.
|
| 5 |
Lin GL, McGinley JP, Drysdale SB, et al. Epidemiology and immune pathogenesis of viral sepsis[J]. Front Immunol, 2018 (9): 2147.
|
| 6 |
Dolin HH, Papadimos TJ, Chen X, et al. Characterization of pathogenic sepsis etiologies and patient profiles: a novel approach to triage and treatment[J]. Microbiol Insights, 2019 (12): 1178636118825081.
|
| 7 |
Li D, Wu M. Pattern recognition receptors in health and diseases[J]. Signal Transduct Target Ther, 2021, 6 (1): 291.
|
| 8 |
Wang PZ, Li ZD, Yu HT, et al. Elevated serum concentrations of inflammatory cytokines and chemokines in patients with haemorrhagic fever with renal syndrome[J]. J Int Med Res, 2012, 40 (2): 648-656.
|
| 9 |
常泽楠，温仕宏，张义楠，等.脓毒症中内皮细胞高通透性的机制研究进展[J/CD].中华危重症医学杂志（电子版），2022，15（4）：337-342.
|
| 10 |
Jiang H, Du H, Wang LM, et al. Hemorrhagic fever with renal syndrome: pathogenesis and clinical picture[J]. Front Cell Infect Microbiol, 2016 (6): 1.
|
| 11 |
Song JW, Zullo J, Lipphardt M, et al. Endothelial glycocalyx—the battleground for complications of sepsis and kidney injury[J]. Nephrol Dial Transplant, 2018, 33 (2): 203-211.
|
| 12 |
Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis[J]. Am J Respir Crit Care Med, 2020, 202 (3): 361-370.
|
| 13 |
Villalba N, Baby S, Yuan SY. The endothelial glycocalyx as a double-edged sword in microvascular homeostasis and pathogenesis[J]. Front Cell Dev Biol, 2021 (9): 711003.
|
| 14 |
彭晓欢，李莉娟，张鸿彬，等.免疫血栓形成——脓毒症中的一把"双刃剑" [J/CD].中华危重症医学杂志（电子版），2022，15（3）：241-245.
|
| 15 |
Mackman N, Grover SP, Antoniak S. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus[J]. J Thromb Haemost, 2021, 19 (11): 2652-2658.
|
| 16 |
Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19[J]. Nat Med, 2020, 26 (7): 1017-1032.
|
| 17 |
卫夏迪，刘虹，李福东，等.脓毒症T淋巴细胞的研究进展[J/CD].中华危重症医学杂志（电子版），2021，14（4）：327-330.
|
| 18 |
孙剑会，刘迪，张华才，等.病毒性脓毒症的发病机制及其对严重急性呼吸综合征冠状病毒2脓毒症治疗的指导意义[J/CD].中华危重症医学杂志（电子版），2020，13（1）：8-14.
|
| 19 |
Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)[J]. Front Immunol, 2020 (11): 827.
|
| 20 |
Vandewalle J, Luypaert A, De Bosscher K, et al. Therapeutic mechanisms of glucocorticoids[J]. Trends Endocrinol Metab, 2018, 29 (1): 42-54.
|
| 21 |
Panettieri RA, Schaafsma D, Amrani Y, et al. Non-genomic effects of glucocorticoids: an updated view[J]. Trends Pharmacol Sci, 2019, 40 (1): 38-49.
|
| 22 |
Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience[J]. Chest, 2006, 129 (6): 1441-1452.
|
| 23 |
Sayce AC, Miller JL, Zitzmann N. Glucocorticosteroids as dengue therapeutics: resolving clinical observations with a primary human macrophage model[J]. Clin Infect Dis, 2013, 56 (6): 901-903.
|
| 24 |
Baseler L, Chertow DS, Johnson KM, et al. The pathogenesis of ebola virus disease[J]. Annu Rev Pathol, 2017 (12): 387-418.
|
| 25 |
Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities[J]. Br J Haematol, 2016, 174 (2): 203-217.
|
| 26 |
国家卫生健康委员会，国家中医药管理局.儿童腺病毒肺炎诊疗规范（2019年版）[J].传染病信息，2019，32（4）：293-298.
|
| 27 |
张明真，何海燕，吕波，等.激素治疗腺病毒感染脓毒症的临床研究[J].中国医药指南，2016，14（18）：25，26.
|
| 28 |
Vandewalle J, Libert C. Glucocorticoids in sepsis: to be or not to be[J]. Front Immunol, 2020 (11): 1318.
|
| 29 |
Shimba A, Cui G, Tani-Ichi S, et al. Glucocorticoids drive diurnal oscillations in T cell distribution and responses by inducing interleukin-7 receptor and CXCR4[J]. Immunity, 2018, 48 (2): 286-298.e6.
|
| 30 |
Quatrini L, Wieduwild E, Escaliere B, et al. Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells[J]. Nat Immunol, 2018, 19 (9): 954-962.
|
| 31 |
Heming N, Sivanandamoorthy S, Meng P, et al. Immune effects of corticosteroids in sepsis[J]. Front Immunol, 2018 (9): 1736.
|
| 32 |
Ehrchen JM, Roth J, Barczyk-Kahlert K. More than suppression: glucocorticoid action on monocytes and macrophages[J]. Front Immunol, 2019 (10): 2028.
|
| 33 |
Mathew D, Giles JR, Baxter AE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications[J]. Science, 2020, 369 (6508): eabc8511.
|
| 34 |
杨硕，苏斌涛，陈菁，等.糖皮质激素对新型冠状病毒肺炎患者T淋巴细胞亚群的影响[J].中国呼吸与危重监护杂志，2021，20（3）：159-163.
|
| 35 |
Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia[J]. J Infect Dis, 2020, 221 (11): 1762-1769.
|
| 36 |
Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin[J]. Basic Res Cardiol, 2009, 104 (1): 78-89.
|
| 37 |
Rinaldi S, Adembri C, Grechi S, et al. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria[J]. Crit Care Med, 2006, 34 (9): 2334-2339.
|
| 38 |
中华预防医学会感染性疾病防控分会，中华医学会感染病学分会.肾综合征出血热防治专家共识[J].中华传染病杂志，2021，39（5）：257-265.
|
| 39 |
Kularatne SA. Survey on the management of dengue infection in Sri Lanka: opinions of physicians and pediatricians[J]. Southeast Asian J Trop Med Public Health, 2005, 36 (5): 1198-1200.
|
| 40 |
Min M, U T, Aye M, et al. Hydrocortisone in the management of dengue shock syndrome[J]. Southeast Asian J Trop Med Public Health, 1975, 6 (4): 573-579.
|
| 41 |
Zhang F, Kramer CV. Corticosteroids for dengue infection[J]. Cochrane Database Syst Rev, 2014 (7): CD003488.
|
| 42 |
Shi WL, Zhang T, Zhou JR, et al. Rapid permissive action of dexamethasone on the regulation of blood pressure in a rat model of septic shock[J]. Biomed Pharmacother, 2016 (84): 1119-1125.
|
| 43 |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47 (11): 1181-1247.
|
| 44 |
Fougères E, Teboul JL, Richard C, et al. Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status[J]. Crit Care Med, 2010, 38 (3): 802-807.
|
| 45 |
Kan M, Himes BE. Insights into glucocorticoid responses derived from omics studies[J]. Pharmacol Ther, 2021 (218): 107674.
|
| 46 |
Bhoelan S, Langerak T, Noack D, et al. Hypopituitarism after orthohantavirus infection: what is currently known?[J]. Viruses, 2019, 11 (4): 340.
|
| 47 |
Aneja R, Carcillo JA. What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock?[J]. Arch Dis Child, 2007, 92 (2): 165-169.
|
| 48 |
Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017[J]. Intensive Care Med, 2017, 43 (12): 1751-1763.
|
| 49 |
Liang H, Song H, Zhai R, et al. Corticosteroids for treating sepsis in adult patients: a systematic review and meta-analysis[J]. Front Immunol, 2021 (12): 709155.
|
| 50 |
Vial PA, Valdivieso F, Ferres M, et al. High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial[J]. Clin Infect Dis, 2013, 57 (7): 943-951.
|
| 51 |
郭琴琴，曹大伟，张喆，等.糖皮质激素在病毒性肺炎中的应用[J].国际呼吸杂志，2021，41（11）：825-830.
|
| 52 |
Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A (H1N1)pdm09 viral pneumonia[J]. Influenza Other Respir Viruses, 2017, 11 (4): 345-354.
|
| 53 |
RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19[J]. N Engl J Med, 2021, 384 (8): 693-704.
|
| 54 |
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis[J]. JAMA, 2020, 324 (13): 1330-1341.
|
| 55 |
Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters[J]. Crit Care Med, 2018, 46 (6): 915-925.
|
| 56 |
Antcliffe DB, Burnham KL, Al-Beidh F, et al. Transcriptomic signatures in sepsis and a differential response to steroids. from the VANISH randomized trial[J]. Am J Respir Crit Care Med, 2019, 199 (8): 980-986.
|